Fundz

Gameto Announces New Funding And Preclinical Development Partnerships With Leading Global Fertility Clinics

RECENTLY ACQUIREDSep 14, 2022

Round Type

Funding Round

Bee CaveBiotechnologyHealth Careresearch

Description

Gameto, a biotechnology company using cell engineering to develop therapeutics for diseases of the female reproductive system, today announced that it has raised an additional $17 million in funding from global software investor Insight Partners, Future Ventures, Arcadia Investment Partners, Bold Capital Partners, Plum Alley, Myelin VC, TA Ventures, Gaingels, Korify Capital, and other existing investors. The new financing brings the total capital raised since inception to $40M.

Quick answer

Gameto raised an undisclosed amount in a Funding Round round, dated September 14, 2022. Gameto is based in Bee Cave, Texas, United States.

How much did Gameto raise?
Gameto raised an undisclosed amount in a Funding Round round on September 14, 2022.
What does Gameto do?
Gameto is a women's health biotechnology company advancing programs from a cell engineering platform developed with George Church's lab at Harvard Medical School.
Where is Gameto based and how big is it?
Gameto is based in Bee Cave, Texas, United States. Fundz records about 53 employees.
Who are the decision-makers at Gameto?
Fundz holds 1 contact at Gameto. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Gameto, and when

A new round usually means Gameto is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Gameto raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Gameto, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Gameto. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Gameto

Location

Madison Avenue

Bee Cave, Texas, United States

About

Gameto is a women's health biotechnology company advancing programs from a cell engineering platform developed with George Church's lab at Harvard Medical School. Founded by Dr. Dina Radenkovic, a medical doctor-turned-entrepreneur, and Martin Varsavsky, founder of one of North America's largest fertility clinic network, Inception Prelude, Gameto has raised $127 million from leading investors to develop therapies that address fertility, menopause, and women's and family health. The company's lead program, Fertilo, is currently in Phase 3 clinical trials.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Gameto raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts hidden hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Gameto's next move

See what Strategic adds

Gameto raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.